
The study authors said that their analysis found that an expensive new branded formulation of PrEP -- touted as being safer by the company that makes it -- would in reality be no better than cheaper generics.
The study authors said that their analysis found that an expensive new branded formulation of PrEP -- touted as being safer by the company that makes it -- would in reality be no better than cheaper generics.